HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prolonged remission of neuro-Behcet disease following autologous transplantation.

Abstract
Two young male patients with severe progressive Behcet's disease with neurological involvement (N-BD) were treated by high-dose immunosuppressive chemotherapy (HIC) followed by autologous CD34+ selected peripheral blood stem cell transplantation (APBSCT). Neurological impairment and disability were quantified by means of Expanded Disability Status Scale (EDSS). Neuroimaging included spine and brain MRI and brain SPECT by radiolabeling technetium (Tc99m) Ethyl Cisteynate Dimer (ECD). Disease progression halted after treatment in both patients. At 48 months of follow-up they were therapy-free and one showed neurological status and disability improvement. Brain MRI findings were unchanged in both patients, but SPECT-ECD showed an increase of blood flow in the hypoperfused cerebral areas in the ameliorated patient. Immune ablation followed by APBSCT can modify the course of severe N-BD. Because of the high risk and the transplant-related mortality, these cases have to be carefully selected.
AuthorsA De Cata, D Intiso, M Bernal, F Molinaro, G Mazzoccoli, V D'Alessandro, A Greco, S Curci, M Sperandeo, V Frusciante, G Famularo, B Dallapiccola, G Vendemiale
JournalInternational journal of immunopathology and pharmacology (Int J Immunopathol Pharmacol) 2007 Jan-Mar Vol. 20 Issue 1 Pg. 91-6 ISSN: 0394-6320 [Print] England
PMID17346431 (Publication Type: Journal Article)
Chemical References
  • Antigens, CD34
  • Immunosuppressive Agents
Topics
  • Adult
  • Antigens, CD34
  • Behcet Syndrome (diagnostic imaging, physiopathology, therapy)
  • Brain (pathology)
  • Disability Evaluation
  • Female
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Magnetic Resonance Imaging
  • Male
  • Neurologic Examination
  • Risk
  • Spinal Cord (pathology)
  • Tomography, Emission-Computed, Single-Photon
  • Transplantation, Autologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: